Consumer comments open for CAR-T cell therapy funding for my...
Every week, 38 Australians are diagnosed with myeloma, an in...
Myeloma Australia welcomes today’s announcement by the Feder...
At the upcoming Pharmaceutical Benefits Advisory Committee (...
Lenalidomide (Revlimid®) maintenance post autologous stem ce...
Our Information and Support Groups are informal gatherings f...
Call our support line
Donate to Myeloma Australia